← All trials
NCT04374994
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2018
- Primary completion
- Apr 15, 2019
- Completion date
- Oct 10, 2019
- First posted
- May 5, 2020
- Last posted
- May 8, 2020
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Alexandria UniversityLead sponsor
- Alexandria UniversityStudy director
- Alexandria UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.